ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Is neutrophil/lymphocyte and platelet/lymphocyte ratio a predictive factor for the fibrous stage in patients with chronic hepatitis B?

Sevki Konur, Neslihan Surmeli, Adnan Ozkahraman, Ramazan Dertli, Yusuf Kayar.




Abstract
Cited by 1 Articles

Aim: Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are an inexpensive inflammatory marker that can be easily obtained from the blood count and can be used in many chronic diseases. In our study, we aimed to investigate the relationship between fibrosis stage and NLR, PLR in patients with chronic hepatitis B virus (HBV).
Materials and Methods: 173 patients with chronic HBV were included in the study. The demographic data and hemogram parameters of all patients were recorded. Histopathological data of the patients were documented. Accompanying comorbid diseases, medications and previous operations were questioned. In chronic HBV patients, fibrosis level was compared with hematological parameters.
Results: A total of 173 patients, 100 (57.8%) of whom were male, were included in the study. As a result of the liver biopsy; mild fibrosis (steage/1-2) in 83(47.9%) patients, moderate fibrosis (steage/3-4) in 35(20.3%) patients and advanced fibrosis (stage/5-6) in 55(31.8%) patients. In advanced fibrosis group, liver function tests and bilirubin levels were significantly higher and albumin level was significantly lower (p

Key words: Chronic Hepatitis B; fibrosis; NLR; PLR






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.